Cosmo Pharmaceuticals N.V. (0RGI.L)
CHF 59.0
(-1.5%)
CHF 59.0
(-1.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 92.78 Million | 102.08 Million | 65.07 Million | 60.94 Million | 62.49 Million | 65.61 Million |
| Cost of Revenue | 18.83 Million | 18.76 Million | 15.14 Million | 10.44 Million | 9.24 Million | 12.37 Million |
| Gross Profit | 73.94 Million | 83.32 Million | 49.93 Million | 50.5 Million | 53.24 Million | 53.24 Million |
| Operating Expenses | 47.29 Million | 55.27 Million | 38.83 Million | 43.6 Million | 65.55 Million | 69.86 Million |
| Selling, General and Administrative Expenses | 30.79 Million | 3.55 Million | 2.8 Million | 4.48 Million | 9.85 Million | 18.24 Million |
| Research and Development Expenses | 18.81 Million | 15.52 Million | 11.35 Million | 13.59 Million | 15.69 Million | 10.52 Million |
| Other Expenses | -2.31 Million | 51.72 Million | 36.02 Million | 39.11 Million | 55.7 Million | 51.62 Million |
| Cost and Expenses | 86.63 Million | 74.03 Million | 53.97 Million | 54.04 Million | 74.8 Million | 82.23 Million |
| Operating Income | 6.14 Million | 28.05 Million | 33.11 Million | 2.05 Million | -12.3 Million | -16.62 Million |
| Interest Expense | 8.52 Million | 9.15 Million | 8.99 Million | 8.73 Million | 8.52 Million | 647 Thousand |
| Income Tax Expense | 6.26 Million | 6.96 Million | 2.33 Million | 970 Thousand | 3.19 Million | 598 Thousand |
| Earnings before Tax | 1.53 Million | 24.47 Million | 24 Million | -6.93 Million | -21.3 Million | -17.45 Million |
| Net Income | -4.93 Million | 17.22 Million | 21.67 Million | -7.9 Million | -24.49 Million | -18.05 Million |
| Earnings Per Share Basic | -0.31 | 1.05 | 1.29 | -0.55 | -1.67 | -1.20 |
| Earnings Per Share Diluted | -0.31 | 1.05 | 1.28 | -0.55 | -1.67 | -1.20 |
| Weighted Average Shares Outstanding | 16.1 Million | 16.42 Million | 16.84 Million | 14.47 Million | 14.62 Million | 15 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.1 Million | 16.42 Million | 16.9 Million | 14.47 Million | 14.63 Million | 15 Million |
| Gross Margin | 0.80 | 0.82 | 0.77 | 0.83 | 0.85 | 0.81 |
| EBIT Margin | 0.21 | 0.47 | 0.62 | 0.13 | -0.15 | -0.16 |
| Profit Margin | -0.05 | 0.17 | 0.33 | -0.13 | -0.39 | -0.28 |
| EBITDA | 19.69 Million | 47.48 Million | 40.48 Million | 7.83 Million | -7.02 Million | -12.32 Million |
| Earnings Before Tax Margin | 0.07 | 0.27 | 0.51 | 0.03 | -0.20 | -0.25 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 68.11 Million | 68.11 Million | 24.55 Million | 92.78 Million | 24.55 Million | 21.83 Million |
| Cost of Revenue | 11.57 Million | 11.57 Million | 10.23 Million | 18.83 Million | 10.23 Million | 9.43 Million |
| Gross Profit | 56.54 Million | 56.54 Million | 14.32 Million | 73.94 Million | 14.32 Million | 12.39 Million |
| Operating Expenses | 13.06 Million | 12.64 Million | 14.64 Million | 66.77 Million | 14.64 Million | 9.07 Million |
| Selling, General and Administrative Expenses | 8.16 Million | 8.16 Million | 10.49 Million | - | 10.49 Million | 4.9 Million |
| Research and Development Expenses | 5.41 Million | 5.41 Million | 5.26 Million | - | 5.26 Million | 4.14 Million |
| Other Expenses | -507 Thousand | - | - | - | - | - |
| Cost and Expenses | 24.64 Million | 24.21 Million | 24.87 Million | 85.61 Million | 24.87 Million | 18.51 Million |
| Operating Income | 43.47 Million | 43.47 Million | -488.5 Thousand | 6.14 Million | -488.5 Thousand | 3.56 Million |
| Interest Expense | - | - | - | 8.52 Million | - | 4.54 Million |
| Income Tax Expense | 6.34 Million | 6.34 Million | 2.03 Million | 6.26 Million | 2.03 Million | 1.09 Million |
| Earnings before Tax | 44.37 Million | 44.37 Million | -1.07 Million | 1.53 Million | -1.07 Million | 1.83 Million |
| Net Income | 37.99 Million | 37.99 Million | -3.2 Million | -4.93 Million | -3.2 Million | 743 Thousand |
| Earnings Per Share Basic | 2.35 | 2.35 | -0.20 | - | -0.20 | 0.05 |
| Earnings Per Share Diluted | 2.35 | 2.35 | -0.20 | - | -0.20 | 0.05 |
| Weighted Average Shares Outstanding | 16.15 Million | 16.15 Million | 16.06 Million | 16.1 Million | 16.06 Million | 16.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.15 Million | 16.15 Million | 16.06 Million | 16.1 Million | 16.06 Million | 16.14 Million |
| Gross Margin | 0.83 | 0.83 | 0.58 | 0.80 | 0.58 | 0.57 |
| EBIT Margin | 0.69 | 0.69 | 0.12 | - | 0.12 | 0.32 |
| Profit Margin | 0.56 | 0.56 | -0.13 | -0.05 | -0.13 | 0.03 |
| EBITDA | 47.12 Million | 47.12 Million | 2.83 Million | - | 2.83 Million | 7.01 Million |
| Earnings Before Tax Margin | 0.64 | 0.64 | -0.02 | 0.07 | -0.02 | 0.16 |
4551
3035
BHF
7570
WGLIF
EPIX